SCHEMBL15569560

SCHEMBL15569560

Cc1nc(-c2cccc(S(=O)(=O)N3CCN(c4nc5ccccc5n4Cc4ccc(F)cc4)CC3)c2)no1

nearest known ligand 0.56

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ HRH1 P35367 10/20 0.49
▸ CYP2D6 P10635 9/20 0.49
▸ KCNH2 Q12809 4/20 0.49
▸ LMNA P02545 3/20 0.49
▸ TP53 P04637 2/20 0.49
▸ HTR3A P46098 1/20 0.49
▸ MAPT P10636 5/20 0.48
▸ CHRM1 P11229 3/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.47
▸ USP2 O75604 1/20 0.45
▸ POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15568616 0.82 LMNA (0.49) CYP2D6LMNATP53MAPTNPSR1
SCHEMBL15569125 0.80 PKM (0.60) PKMSMN1; SMN2HRH1CYP2D6KCNH2
SCHEMBL15568082 0.80 HRH1 (0.47) HRH1CYP2D6KCNH2LMNATP53
SCHEMBL15568646 0.75 PKM (0.60) PKMSMN1; SMN2HRH1CYP2D6KCNH2
SCHEMBL15568900 0.73 GAA (0.53) PKMHRH1CYP2D6KCNH2HTR3A
SCHEMBL15569119 0.73 PKM (0.59) PKMSMN1; SMN2HRH1CYP2D6KCNH2
SCHEMBL15567339 0.72 PKM (0.60) PKMSMN1; SMN2HRH1CYP2D6KCNH2
SCHEMBL15569126 0.71 HRH1 (0.66) PKMHRH1CYP2D6KCNH2HTR3A
SCHEMBL15567208 0.70 HRH1 (0.56) HRH1CYP2D6KCNH2HTR3ACHRM1
SCHEMBL15568787 0.69 HRH1 (0.62) PKMHRH1CYP2D6KCNH2HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 — — WO claimed
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 — — WO disclosed
Send feedback